The failure to conceive or bring a pregnancy to full term is referred to as infertility. Infertility may have a wide variety of causes. The hormone imbalance, a tumor or cyst, alcohol or drug use, eating disorders such as anorexia or bulimia, thyroid gland problems, excess weight, stress and many others are some of the major causes of infertility. The treatment methods that are used to infertility condition in both male and female is known as infertility treatment. Many infertility treatments increase the chances of becoming pregnant significantly. They include fertility drugs, hormone treatments, and surgery among others.
The growth of the infertility treatment market is projected to be driven by factors such as increase in worldwide infertility rates, delayed pregnancies in women, rise in gamete donations, growing advancements in technologies that are associated with infertility treatment devices, high disposable income of the people, surge in the success rate of treatment, and ever-increasing global healthcare expenditure. However, factors such as complications related to infertility treatment, and low awareness level of infertility treatment in developing nations are anticipated to hamper the growth of the market. Conversely, growing number of fertility hospitals and clinics, and rising public-private funds, investments, and grants are anticipated to offer lucrative growth opportunities to the market.
The study analyses global infertility treatment market based on product, procedure, patient type, end user and geography.
Based on product, media & consumables segment is likely to experience fast growth during the projection period. The easy and massive availability of a variety of media and consumables across all regions is major factor that accredited to the growth of this segment. Likewise, factors such as growing technological advancements in the field of consumable devices, growing awareness of infertility treatment and diagnosis worldwide is expanding the growth of this segment.
Based on procedure, artificial insemination segment projected to hold second-largest market share. Artificial insemination is a fertility treatment procedure that involves injecting sperm directly into the cervix or uterus with the hope of conceiving. The factors such as high success rate achieved by the couple by using this procedure and limited risk of complications during pregnancy are projected to propel growth of this segment.
Based on patient type, female infertility treatment segment is projected to witness fast growth during the forecast period. Infertility is one of the most frequently diagnosed disorders among women. An increasing female infertility rates, growing awareness among women regarding infertility treatments, the vast availability of various treatment options, and rising number of fertility centers are some of the major factors that attributed to the healthy growth of the segment.
Based on the end user, hospital segment dominated the market in 2020 and is likely to maintain its dominance at high growth rate during the forecast period. Rising preference of the people towards hospitals for treatment of infertility is major driving factor that is attributed to the segment growth. In addition to the treatment, hospitals provide whole maternity treatment till childbirth. Thus increased dependency on the hospitals is further expanding the market growth.
Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World. North America held the largest market share of global infertility treatment market and is likely to dominate the market over the estimated time frame. The US and Canada are dominated the market in this region. The major factors that attributed to the growth of market in this region are increasing median age of first-time pregnancy, decreasing fertility rates, ever-growing healthcare expenditure, and existence of key players such as Cook Group Incorporated, The Cooper Companies, Inc, and Hamilton Throne Ltd. Additionally, high income, rising awareness, and good reimbursement scenario are further fuelling the market growth in the region.
The major key players of market includes Cook Group Incorporated, Esco Micro Pte. Ltd, Genea Limited, Hamilton Throne, Ltd, Ihmedical A/S, Irvine Scientific (A Member of Jx Holdings Group), IVFTech Aps, Kitazato Corporation, Medgyn Products, Inc, Rocket Medical PLC, Somatex Medical Technologies GmbH, The Baker Company, Inc, The Cooper Companies, Inc, Thermo Fisher Scientific, Vitrolife Ab and Zeiss Group among others.
The study analyses global Infertility Treatment market based on product, procedure, patient type, end user and geography. Infertility Treatment market by product is segmented into equipment, media & consumables, and accessories. The media & consumables segment is likely to dominate the market over the forecast period. Increased adoption of media & consumables in hospitals is attributed to the market growth. By procedure, the market is segmented into assisted reproductive technology, artificial insemination, fertility surgery, and other infertility treatment procedures. By patient type, the market is segmented into female infertility treatment and male infertility treatment. The female infertility treatment segment is likely to register fastest growth in years to come owing to the growing infertility symptoms among women across the globe. Based on end user market is segmented into cryobanks, fertility centers, hospitals & surgical clinics, and research institutes.Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World.
Why to buy this report: